JHERX Performance — Equity Income Fund, Class C
Data updated: 2026-09-24
JHERX returned +11.25% year to date and +22.43% over one year to May 2026. Annualised returns are +16.04% over 3 years and +7.99% over 5 years. The fund beat its US Multi-Cap Value category average: $100 invested three years ago grew to $156, against $151 for the category, and to $122 over one year, against $117. Volatility over the past three years was 12.71% a year. In the 12 months to May 2026 the fund took in a net $373.0M, and assets reached $596.80M.
JHERX Growth of $100
What $100 invested in Equity Income Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Multi-Cap Value category average over the same months.
| Period | JHERX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $122 | $117 |
| 3 years (Jun 2023 – May 2026) | $156 | $151 |
| 5 years (Jun 2021 – May 2026) | $147 | $144 |
| Since data start (Sep 2019 – May 2026) | $196 | $192 |
JHERX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +11.25% |
| 1 year | +22.43% |
| 3 years (annualised) | +16.04% |
| 5 years (annualised) | +7.99% |
JHERX Annual Returns
Calendar-year total returns of Equity Income Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +11.25% |
| 2025 | +12.48% |
| 2024 | +10.44% |
| 2023 | +8.27% |
| 2022 | −4.50% |
| 2021 | +24.12% |
| 2020 | −0.05% |
| 2019 (Sep–Dec) | +10.59% |
JHERX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.7% | +2.5% | −5.3% | +7.9% | +2.4% | — | — | — | — | — | — | — |
| 2025 | +4.5% | +0.9% | −1.7% | −5.0% | +3.8% | +2.7% | −0.9% | +4.1% | +0.3% | −0.5% | +2.1% | +2.0% |
| 2024 | −0.3% | +3.9% | +4.7% | −3.2% | +3.5% | −1.3% | +3.8% | +2.0% | +0.7% | −1.4% | +4.8% | −6.5% |
| 2023 | +5.5% | −3.8% | −2.4% | +2.1% | −5.3% | +6.4% | +4.0% | −4.0% | −3.4% | −2.6% | +7.3% | +5.3% |
| 2022 | +0.9% | −0.1% | +1.6% | −5.5% | +2.9% | −8.5% | +5.0% | −2.0% | −9.4% | +10.2% | +6.5% | −4.2% |
| 2021 | −0.4% | +6.5% | +6.7% | +4.0% | +2.7% | −2.5% | −0.7% | +2.2% | −2.7% | +4.2% | −3.7% | +6.4% |
| 2020 | −3.1% | −10.3% | −18.0% | +9.5% | +2.8% | +0.5% | +3.8% | +3.1% | −3.9% | −0.5% | +16.3% | +4.2% |
| 2019 | — | — | — | — | — | — | — | — | +3.7% | +0.5% | +3.2% | +2.8% |
JHERX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 12.71%
- 3-year Sharpe ratio: 0.91 (vs 4.5% risk-free rate)
- Best month: +7.89% (Apr 2026)
- Worst month: −6.48% (Dec 2024)
JHERX Fund Flows
Monthly money in and out of Equity Income Fund, from SEC Form N-PORT.
- 12-month net flow: $373.0M
- 12-month gross sales (incl. reinvestments): $509.3M
- Sales ÷ redemptions: 3.74×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $1.0M | $11.4M | −$10.4M |
| Apr 2026 | $3.1M | $9.0M | −$5.9M |
| Mar 2026 | $2.7M | $7.9M | −$5.2M |
| Feb 2026 | $1.9M | $10.9M | −$9.1M |
| Jan 2026 | $2.2M | $17.1M | −$14.9M |
| Dec 2025 | $208.7M | $20.3M | $188.5M |
| Nov 2025 | $883K | $13.5M | −$12.6M |
| Oct 2025 | $1.8M | $14.0M | −$12.1M |
| Sep 2025 | $1.9M | $7.6M | −$5.6M |
| Aug 2025 | $1.7M | $9.1M | −$7.4M |
| Jul 2025 | $281.0M | $9.1M | $271.9M |
| Jun 2025 | $2.4M | $6.6M | −$4.2M |
JHERX Assets Under Management
Net assets of Equity Income Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $596.80M |
| 2026-02-28 | $591.29M |
| 2025-11-30 | $584.28M |
| 2025-08-31 | $603.59M |
| 2025-05-31 | $318.09M |
| 2025-02-28 | $1.67B |
| 2024-11-30 | $1.80B |
| 2024-08-31 | $1.77B |
| 2024-05-31 | $1.72B |
| 2024-02-29 | $1.71B |
| 2023-11-30 | $1.61B |
| 2023-08-31 | $1.73B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.